Oppenheimer Asset Management Inc. Novartis Ag Transaction History

Oppenheimer Asset Management Inc.

  • $8.04 Billion
  • Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Novartis Ag stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 229,901 shares of NVS stock, worth $23.8 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
229,901
Previous 290,113 20.75%
Holding current value
$23.8 Million
Previous $30.9 Million 14.38%
% of portfolio
0.33%
Previous 0.41%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$106.13 - $120.89 $6.39 Million - $7.28 Million
-60,212 Reduced 20.75%
229,901 $26.4 Million
Q2 2024

Aug 08, 2024
BUY
$92.57 - $107.37 $2.89 Million - $3.35 Million
31,180 Added 12.04%
290,113 $30.9 Million
Q1 2024

May 06, 2024
BUY
$95.27 - $108.47 $1.85 Million - $2.11 Million
19,468 Added 8.13%
258,933 $25 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $438,282 - $482,315
-4,750 Reduced 1.95%
239,465 $24.2 Million
Q3 2023

Nov 07, 2023
SELL
$94.73 - $105.13 $1.38 Million - $1.53 Million
-14,591 Reduced 5.64%
244,215 $24.9 Million
Q2 2023

Aug 02, 2023
SELL
$92.52 - $104.91 $4.05 Million - $4.59 Million
-43,782 Reduced 14.47%
258,806 $26.1 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $29,050 - $33,690
-363 Reduced 0.12%
302,588 $27.8 Million
Q4 2022

Feb 06, 2023
SELL
$75.55 - $92.52 $507,998 - $622,104
-6,724 Reduced 2.17%
302,951 $27.5 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $3.28 Million - $3.84 Million
-44,010 Reduced 12.44%
309,675 $23.5 Million
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $515,408 - $600,093
-6,401 Reduced 1.78%
353,685 $29.9 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $2.14 Million - $2.42 Million
26,754 Added 8.03%
360,086 $31.6 Million
Q4 2021

Feb 02, 2022
BUY
$79.7 - $88.13 $95,480 - $105,579
1,198 Added 0.36%
333,332 $29.2 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $599,856 - $697,851
7,335 Added 2.26%
332,134 $27.2 Million
Q2 2021

Aug 03, 2021
BUY
$85.24 - $94.15 $1.95 Million - $2.15 Million
22,819 Added 7.56%
324,799 $29.6 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $241,565 - $284,873
2,893 Added 0.97%
301,980 $25.8 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $30,915 - $37,394
396 Added 0.13%
299,087 $28.2 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $563,808 - $624,624
-6,864 Reduced 2.25%
298,691 $26 Million
Q2 2020

Aug 11, 2020
SELL
$80.93 - $91.1 $612,316 - $689,262
-7,566 Reduced 2.42%
305,555 $26.7 Million
Q1 2020

May 08, 2020
BUY
$70.67 - $99.01 $97,524 - $136,633
1,380 Added 0.44%
313,121 $25.8 Million
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $806,554 - $911,927
9,562 Added 3.16%
311,741 $29.5 Million
Q3 2019

Oct 31, 2019
SELL
$85.54 - $94.26 $322,058 - $354,888
-3,765 Reduced 1.23%
302,179 $26.3 Million
Q2 2019

Aug 09, 2019
BUY
$75.4 - $92.8 $1.02 Million - $1.25 Million
13,495 Added 4.61%
305,944 $27.9 Million
Q1 2019

Apr 24, 2019
BUY
$75.32 - $86.15 $199,221 - $227,866
2,645 Added 0.91%
292,449 $28.1 Million
Q4 2018

Jan 30, 2019
SELL
$73.66 - $82.02 $325,798 - $362,774
-4,423 Reduced 1.5%
289,804 $24.9 Million
Q3 2018

Oct 26, 2018
BUY
$66.94 - $77.43 $1.19 Million - $1.38 Million
17,792 Added 6.44%
294,227 $25.4 Million
Q2 2018

Aug 10, 2018
BUY
$64.91 - $73.36 $190,121 - $214,871
2,929 Added 1.07%
276,435 $20.9 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $1.08 Million - $1.29 Million
15,368 Added 5.95%
273,506 $22.1 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $19.1 Million - $19.9 Million
258,138
258,138 $22.2 Million

Others Institutions Holding NVS

# of Institutions
1,425
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email